Literature DB >> 19153380

Intranasal insulin improves cognition and modulates beta-amyloid in early AD.

Mandip S Dhamoon, James M Noble, Suzanne Craft.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19153380     DOI： 10.1212/01.wnl.0000344246.91081.2c

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  25 in total

Review 1.  Role of insulin resistance in Alzheimer's disease.

Authors:  Zhiyou Cai; Ming Xiao; Liying Chang; Liang-Jun Yan
Journal:  Metab Brain Dis       Date:  2014-11-16       Impact factor: 3.584

Review 2.  Diabetes type II: a risk factor for depression-Parkinson-Alzheimer?

Authors:  Peter Riederer; Jasmin Bartl; Gerd Laux; Edna Grünblatt
Journal:  Neurotox Res       Date:  2010-06-15       Impact factor: 3.911

Review 3.  Generating new neurons to circumvent your fears: the role of IGF signaling.

Authors:  R C Agis-Balboa; A Fischer
Journal:  Cell Mol Life Sci       Date:  2013-03-30       Impact factor: 9.261

4.  An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.

Authors:  Theresa R Bomfim; Leticia Forny-Germano; Luciana B Sathler; Jordano Brito-Moreira; Jean-Christophe Houzel; Helena Decker; Michael A Silverman; Hala Kazi; Helen M Melo; Paula L McClean; Christian Holscher; Steven E Arnold; Konrad Talbot; William L Klein; Douglas P Munoz; Sergio T Ferreira; Fernanda G De Felice
Journal:  J Clin Invest       Date:  2012-04       Impact factor: 14.808

Review 5.  The many faces of insulin-like peptide signalling in the brain.

Authors:  Ana M Fernandez; Ignacio Torres-Alemán
Journal:  Nat Rev Neurosci       Date:  2012-03-20       Impact factor: 34.870

6.  Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain.

Authors:  Chia-Chen Liu; Jin Hu; Chih-Wei Tsai; Mei Yue; Heather L Melrose; Takahisa Kanekiyo; Guojun Bu
Journal:  J Neurosci       Date:  2015-04-08       Impact factor: 6.167

7.  Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study.

Authors:  Aaron M Koenig; Dawn Mechanic-Hamilton; Sharon X Xie; Martha F Combs; Anne R Cappola; Long Xie; John A Detre; David A Wolk; Steven E Arnold
Journal:  Alzheimer Dis Assoc Disord       Date:  2017 Apr-Jun       Impact factor: 2.703

8.  Neuronal overexpression of insulin receptor substrate 2 leads to increased fat mass, insulin resistance, and glucose intolerance during aging.

Authors:  J Zemva; M Udelhoven; L Moll; S Freude; O Stöhr; H S Brönneke; R B Drake; W Krone; M Schubert
Journal:  Age (Dordr)       Date:  2012-11-17

9.  The relationship between fasting serum glucose and cerebral glucose metabolism in late-life depression and normal aging.

Authors:  Christopher M Marano; Clifford I Workman; Christopher H Lyman; Elisse Kramer; Carol R Hermann; Yilong Ma; Vijay Dhawan; Thomas Chaly; David Eidelberg; Gwenn S Smith
Journal:  Psychiatry Res       Date:  2014-02-01       Impact factor: 3.222

10.  Brain Uptake of Neurotherapeutics after Intranasal versus Intraperitoneal Delivery in Mice.

Authors:  Mihir B Chauhan; Neelima B Chauhan
Journal:  J Neurol Neurosurg       Date:  2015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.